Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
MDT or PODD: Which Is the Better Value Stock Right Now?
12:47pm, Wednesday, 23'rd Aug 2023
Investors interested in Medical - Products stocks are likely familiar with Medtronic (MDT) and Insulet (PODD). But which of these two stocks offers value investors a better bang for their buck right n
Insulet (PODD) Q2 Earnings Beat, Sales Growth View Raised
12:12pm, Wednesday, 09'th Aug 2023
Insulet's (PODD) Omnipod 5 gains market share in the second quarter within the diabetes technology market as the only FDA-approved fully disposable, pod-based automated insulin delivery system.
Insulet (PODD) Tops Q2 Earnings and Revenue Estimates
06:57pm, Tuesday, 08'th Aug 2023
Insulet (PODD) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to loss of $0.06 per share a year ago.
Here's What Key Metrics Tell Us About Insulet (PODD) Q2 Earnings
06:57pm, Tuesday, 08'th Aug 2023
The headline numbers for Insulet (PODD) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Insulet lifts sales growth forecast on strong demand for insulin pumps
05:05pm, Tuesday, 08'th Aug 2023
Insulet Corp on Tuesday raised its annual revenue growth forecast and beat second-quarter profit and revenue estimates, on strong demand for its tubeless insulin pumps that are more convenient to use
Here's Why You Should Retain Insulet (PODD) Stock for Now
09:55am, Tuesday, 08'th Aug 2023
Investors continue to be optimistic about Insulet (PODD) on the strength of the Omnipod 5 AID system.
Healthcare creating more opportunities for tech investors, says Harris Financial's Jamie Cox
02:48pm, Friday, 21'st Jul 2023
Jamie Cox, Harris Financial Group managing partner, joins 'The Exchange' to discuss investment opportunities in medical devices, the intersection of healthcare and technology, and top picks in the med
Insulet to Announce Second Quarter 2023 Financial Results on August 8, 2023
06:00am, Wednesday, 05'th Jul 2023
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
ESLOY vs. PODD: Which Stock Is the Better Value Option?
12:51pm, Wednesday, 28'th Jun 2023
Investors looking for stocks in the Medical - Products sector might want to consider either EssilorLuxottica Unsponsored ADR (ESLOY) or Insulet (PODD). But which of these two stocks is more attractive
Here's Why You Should Retain Insulet (PODD) Stock for Now
03:34pm, Wednesday, 21'st Jun 2023
Investors are optimistic about Insulet (PODD) owing to strength in Omnipod 5 and its focus on market expansion.
ESLOY or PODD: Which Is the Better Value Stock Right Now?
12:43pm, Monday, 12'th Jun 2023
Investors with an interest in Medical - Products stocks have likely encountered both EssilorLuxottica Unsponsored ADR (ESLOY) and Insulet (PODD). But which of these two companies is the best option fo
Insulet Corporation: Margins Are On A Diet
05:33pm, Monday, 05'th Jun 2023
Insulet Corporation aims to continue to revolutionize the diabetes market. The company has seen strong commercial traction, driven by the Omnipod 5, although operating leverage is still hard to come b
Here's Why You Should Retain Insulet (PODD) Stock for Now
09:38am, Tuesday, 23'rd May 2023
Investors continue to be optimistic about Insulet (PODD) on the robust performance of Omnipod 5.
HAE or PODD: Which Is the Better Value Stock Right Now?
12:50pm, Monday, 22'nd May 2023
Investors with an interest in Medical - Products stocks have likely encountered both Haemonetics (HAE) and Insulet (PODD). But which of these two stocks presents investors with the better value opport
3 Top Stocks to Buy Now for Stellar Earnings Growth
08:24am, Tuesday, 09'th May 2023
Stocks such as Franklin Electric (FELE), Insulet (PODD) & Wingstop (WING) have striking earnings growth and positive estimate revisions.
